CorMedix CRMD
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$817.4K (13 inflow days, 7 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 29.7% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 22.00% to 18.23% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| American Century Investment Management | Mutual Fund | 2026/Q3 | +2,377,579 | 3.4% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +375,295 | 3.0% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +320,623 | 3.3% |
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +294,509 | 0.4% |
| Morgan Stanley | Public Company | 2026/Q3 | +217,816 | 0.8% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +217,816 | 0.8% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +194,451 | 0.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +129,043 | 8.3% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +173,182 | 0.2% |
| Bridgeway Capital Management, LLC | Mutual Fund | 2026/Q3 | +551,664 | 0.9% |
| Armistice Capital LLC | Hedge Fund | 2026/Q3 | +500,000 | 0.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +356,536 | 8.1% |
| Hudson River Trading LLC | Private Company | 2026/Q3 | +333,113 | 0.8% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +318,939 | 0.4% |
| Royce & Associates, LP | Mutual Fund | 2026/Q3 | +288,830 | 2.8% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 17 Sep 2026 | Janet Dillione | Independent Director | Derivative Exercise and Retained | +48,909 | – | 87,382 |
| 28 Aug 2026 | Elizabeth Masson-Hurlburt | Executive VP and Chief Operating & Commercial Officer | Sale to Issuer | -8,076 | $8.30 | 86,106 |
| 28 Aug 2026 | Susan Blum | EVP & Chief Financial Officer | Sale to Issuer | -8,424 | $8.30 | 17,436 |
| 28 Aug 2026 | Kaufman Zelnick | EVP, Chief Legal and Compliance Officer & Corporate Secretary | Sale to Issuer | -8,424 | $8.30 | 101,313 |
| 3 Feb 2026 | Joseph Todisco | CEO & Chairman of the Board of Directors | Other Acquisition | +77,156 | – | 373,664 |
| 3 Feb 2026 | Elizabeth Masson-Hurlburt | Executive VP and Chief Operating & Commercial Officer | Other Acquisition | +36,006 | – | 214,278 |
| 3 Feb 2026 | Kaufman Zelnick | EVP, Chief Legal and Compliance Officer & Corporate Secretary | Other Acquisition | +36,006 | – | – |
| 25 Jan 2026 | Myron Kaplan | Lead Independent Director | Other Acquisition | +30,453 | – | 30,453 |
| 25 Jan 2026 | Alan Dunton | Independent Director | Other Acquisition | +30,453 | – | 30,453 |
| 25 Jan 2026 | Janet Dillione | Independent Director | Other Acquisition | +30,453 | – | 30,453 |
| 25 Jan 2026 | Steven Lefkowitz | Independent Director | Other Acquisition | +30,453 | – | 30,453 |
| 25 Jan 2026 | Robert Stewart | Independent Director | Other Acquisition | +30,453 | – | 30,453 |
| 25 Jan 2026 | Gregory Duncan | Independent Director | Other Acquisition | +30,453 | – | 30,453 |
| 22 Jan 2026 | Joseph Todisco | CEO & Chairman of the Board of Directors | Sale to Issuer | -27,306 | $7.27 | 344,610 |
| 22 Jan 2026 | Joseph Todisco | CEO & Chairman of the Board of Directors | Other Acquisition | +225,900 | – | 352,983 |
| 22 Jan 2026 | Elizabeth Masson-Hurlburt | Executive VP and Chief Operating & Commercial Officer | Sale to Issuer | -10,778 | $7.27 | 76,761 |
| 22 Jan 2026 | Elizabeth Masson-Hurlburt | Executive VP and Chief Operating & Commercial Officer | Other Acquisition | +93,010 | – | 165,772 |
| 22 Jan 2026 | Susan Blum | EVP & Chief Financial Officer | Sale to Issuer | -9,767 | $7.27 | 8,438 |
| 22 Jan 2026 | Susan Blum | EVP & Chief Financial Officer | Other Acquisition | +72,820 | – | 124,301 |
| 22 Jan 2026 | Kaufman Zelnick | EVP, Chief Legal and Compliance Officer & Corporate Secretary | Sale to Issuer | -8,803 | $7.27 | – |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 14,205,973 | 18.2% | 8.4 |
| 15 Oct 2026 | 14,665,697 | 18.8% | 12.7 |
| 30 Sep 2026 | 15,422,728 | 19.8% | 18.9 |
| 15 Sep 2026 | 16,202,272 | 20.8% | 18.5 |
| 31 Aug 2026 | 16,032,112 | 20.6% | 13.0 |
| 14 Aug 2026 | 17,149,908 | 22.0% | 11.1 |
No comments yet — be the first to weigh in on CRMD.
Sign in to join the discussion.